tiprankstipranks
Clinuvel Pharmaceuticals Limited (AU:CUV)
ASX:CUV
Australian Market

Clinuvel Pharmaceuticals Limited (CUV) Income Statement

Compare
60 Followers

Clinuvel Pharmaceuticals Limited Income Statement

Last quarter (Q4 2024), Clinuvel Pharmaceuticals Limited's total revenue was AU$55.38M, an increase of 34.77% from the same quarter last year. In Q4, Clinuvel Pharmaceuticals Limited's net income was AU$24.70M. See Clinuvel Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 88.18MAU$ 78.32MAU$ 65.72MAU$ 47.98MAU$ 32.57M
Gross Profit
AU$ 80.45MAU$ 50.59MAU$ 46.62MAU$ 35.20MAU$ 18.43M
Operating Expenses
AU$ 31.30MAU$ 9.68MAU$ 13.53MAU$ 8.51MAU$ 8.23M
Depreciation and Amortization
AU$ 1.14MAU$ 789.41KAU$ 757.83KAU$ 861.43KAU$ 446.13K
EBITDA
AU$ 56.28MAU$ 46.37MAU$ 35.08MAU$ 26.57MAU$ 11.99M
Operating Income
AU$ 49.15MAU$ 40.91MAU$ 33.08MAU$ 26.70MAU$ 10.20M
Other Income/Expenses
AU$ 1.53MAU$ 1.48MAU$ -1.77MAU$ -983.49KAU$ -1.16M
Pretax Income
AU$ 50.68MAU$ 45.58MAU$ 34.32MAU$ 25.71MAU$ 11.54M
Net Income
AU$ 35.64MAU$ 30.60MAU$ 20.88MAU$ 24.73MAU$ 16.65M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ 0.72AU$ 0.62AU$ 0.42AU$ 0.50AU$ 0.31
Diluted EPS
AU$ 0.70AU$ 0.59AU$ 0.40AU$ 0.48AU$ 0.30
Weighted Average Shares Outstanding
49.83M 49.41M 49.41M 49.41M 49.26M
Weighted Average Shares Outstanding (Diluted)
51.03M 51.82M 51.78M 51.13M 50.46M
Currency in AUD

Clinuvel Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis